3-(氯羰基)苯甲酸甲酯 | 3441-03-0

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(氯羰基)苯甲酸甲酯
• 中文别名: 间苯二甲酸单甲酯单酰氯
• 英文名称: 3-(methoxycarbonyl)benzoyl chloride
• 英文别名: 3-chlorocarbonyl-benzoic acid methyl ester；methyl 3-(chlorocarbonyl)benzoate；methyl 3-(chloroformyl)benzoate；3-(carbomethoxy)benzoyl chloride；3-(methoxycarbonyl)benzoic acid chloride；methyl 3-carbonochloridoylbenzoate
• CAS: 3441-03-0
• 化学式: C₉H₇ClO₃
• mdl: MFCD09702420
• 分子量: 198.606
• InChiKey: UTGGIQHJOAPIPD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  C
• 危险品运输编号：
  UN3261 8/PG 3
• 海关编码：
  2918300090
• WGK Germany：
  3

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : Methyl 3-(chlorocarbonyl)benzoate
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 3441-03-0
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
Skin corrosion (Category 1B), H314
Skin sensitisation (Category 1), H317
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
C Corrosive R22, R34, R43
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Danger
Hazard statement(s)
H302 Harmful if swallowed.
H314 Causes severe skin burns and eye damage.
H317 May cause an allergic skin reaction.
Precautionary statement(s)
P280 Wear protective gloves/ protective clothing/ eye protection/ face
protection.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P310 Immediately call a POISON CENTER or doctor/ physician.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Synonyms : Methyl 3-(chloroformyl)benzoate
Methyl isophthaloyl chloride
3-Chlorocarbonylbenzoic acid methyl ester
Formula : C9H7ClO3
Molecular Weight : 198,60 g/mol
CAS-No. : 3441-03-0
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
3-Chlorocarbonylbenzoic acid methyl ester
CAS-No. 3441-03-0 Acute Tox. 4; Skin Corr. 1B; <= 100 %
Skin Sens. 1; H302, H314,
H317
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
3-Chlorocarbonylbenzoic acid methyl ester
CAS-No. 3441-03-0 C, R22 - R34 - R43 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a
physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Store under inert gas. Moisture sensitive.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection
tested and approved under appropriate government standards such as NIOSH (US) or EN
166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: clear, liquid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing 43 - 45 °C
point
f) Initial boiling point and 174 - 176 °C at 14,7 hPa
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 1,860
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
Elevated temperatures.
Incompatible materials
Strong oxidizing agents, Bases, Water
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 3261 IMDG: 3261 IATA: 3261
UN proper shipping name
ADR/RID: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S. (3-Chlorocarbonylbenzoic acid methyl
ester)
IMDG: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S. (3-Chlorocarbonylbenzoic acid methyl
ester)
IATA: Corrosive solid, acidic, organic, n.o.s. (3-Chlorocarbonylbenzoic acid methyl ester)
Transport hazard class(es)
ADR/RID: 8 IMDG: 8 IATA: 8
Packaging group
ADR/RID: III IMDG: III IATA: III
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(氯羰基)苯甲酸甲酯 在 氯化亚砜 、 2,2,6,6-tetramethylpiperidinylmagnesium chloride lithium chloride complex 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 32.0h， 生成 methyl 3-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-4-hydroxybenzoate
  参考文献：
  名称：

  对 2-(恶唑啉基)-苯酚和 1,2,5-硫属二唑环化衍生物的取代效应：发射颜色可调、极简激发态分子内质子转移 (ESIPT) 基发光体

  摘要：

  合成了被不同给电子和吸电子基团取代的简约 2-(恶唑啉基)-苯酚及其 1,2,5-硫属二唑环化衍生物，并研究了它们在溶液和固体中的发射行为状态。根据引入的取代基的性质及其位置，发射效率会增加或减少，从而产生 AIE 或 ACQ 特性。单晶分析揭示了 J 型和 H 型包装基序以及迄今为止未描述的以酮形式分离的基于 ESIPT 的荧光团。

  DOI：

  10.1021/acs.joc.1c00846
• 作为产物：
  描述：

  间苯二甲酸二甲酯 在 甲醇 、 barium dihydroxide 、 氯化亚砜 作用下， 以 氯仿 为溶剂， 反应 17.0h， 生成 3-(氯羰基)苯甲酸甲酯
  参考文献：
  名称：

  Prostanoids and Related Compounds. V. Synthesis of 6-Aza-5-oxo-2,3,4-trinor-1,5-inter-m-phenylene Prostacyclin Derivatives.

  摘要：

  通过使用1, 3-偶极环加成反应作为关键步骤，合成了6-氮杂-5-氧杂-2, 3, 4-三核-1, 5-间苯基原花青素衍生物。

  DOI：

  10.1248/cpb.39.3175
• 作为试剂：
  描述：

  间苯二甲酸单甲酯 、 草酰氯 、 N,N-二甲基甲酰胺 在 3-(氯羰基)苯甲酸甲酯 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 以This resulted in 6.6 g (87%) of methyl 3-(chlorocarbonyl)benzoate as brown oil的产率得到3-(氯羰基)苯甲酸甲酯
  参考文献：
  名称：

  Compounds and methods for inhibiting phosphate transport

  摘要：

  本发明揭示了具有磷酸盐转运抑制活性的化合物，更具体地说，是肠道顶端膜Na/磷酸盐共转运的抑制剂。这些化合物具有以下结构（I）：包括立体异构体，其药学上可接受的盐和前药，其中X、Y和A如此定义。本发明还揭示了与制备和使用这种化合物相关的方法，以及包含这种化合物的制药组合物。

  公开号：

  US08809339B2

文献信息

• [EN] NITROGEN RING CONTAINING COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISORDERS<br/>[FR] COMPOSÉS CONTENANT UN CYCLE AZOTÉ POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES
  申请人：WEINGARTEN M DAVID

  公开号：WO2012135669A1

  公开（公告）日：2012-10-04

  The invention provides compounds, pharmaceutical compositions and methods of treatment of inflammatory disorders including a compound of Formula I, or its pharmaceutically acceptable salt, ester, pharmaceutically acceptable derivative or prodrug wherein R1, R2, R3, R4, X, Y, W, Z and Q are as defined herein.

  这项发明提供了化合物、药物组合物和治疗炎症性疾病的方法，包括式I的化合物，或其药用可接受的盐、酯、药用可接受的衍生物或前药，其中R1、R2、R3、R4、X、Y、W、Z和Q如本文所定义。
• Functional Group Transposition: A Palladium-Catalyzed Metathesis of Ar–X σ-Bonds and Acid Chloride Synthesis
  作者：Maximiliano De La Higuera Macias、Bruce A. Arndtsen

  DOI：10.1021/jacs.8b06605

  日期：2018.8.15

  development of a new method to use palladium catalysis to form functionalized aromatics: via the metathesis of covalent σ-bonds between Ar-X fragments. This transformation demonstrates the dynamic nature of palladium-based oxidative addition/reductive elimination and offers a straightforward approach to incorporate reactive functional groups into aryl halides through exchange reactions. The reaction has

  我们描述了一种使用钯催化形成功能化芳烃的新方法的开发：通过 Ar-X 片段之间的共价 σ 键的复分解。这种转变证明了基于钯的氧化加成/还原消除的动态特性，并提供了一种通过交换反应将反应性官能团结合到芳基卤化物中的直接方法。该反应已被用于在不使用高能卤化或有毒试剂的情况下组装酰氯，而是通过芳基碘与其他酰氯的复分解。
• Decarbonylative Suzuki–Miyaura Cross-Coupling of Aroyl Chlorides
  作者：Tongliang Zhou、Pei-Pei Xie、Chong-Lei Ji、Xin Hong、Michal Szostak

  DOI：10.1021/acs.orglett.0c02250

  日期：2020.8.21

  Herein, we report a catalyst system for Pd-catalyzed decarbonylative Suzuki–Miyaura cross-coupling of aroyl chlorides with boronic acids to furnish biaryls. This strategy is suitable for a broad range of common aroyl chlorides and boronic acids. The synthetic utility is highlighted in the direct late-stage functionalization of pharmaceuticals and natural products capitalizing on the presence of carboxylic

  在此，我们报告了一种用于 Pd 催化的芳酰氯与硼酸脱羰 Suzuki-Miyaura 交叉偶联以提供联芳基化合物的催化剂体系。该策略适用于范围广泛的常见芳酰氯和硼酸。利用羧酸部分的存在，药物和天然产品的直接后期功能化突出了合成效用。广泛的机理和 DFT 研究提供了对反应机理和高脱羰交叉偶联选择性的关键见解。
• Nitrogen-containing fused ring compounds and use thereof
  申请人：Hirata Kazuyuki

  公开号：US20070010670A1

  公开（公告）日：2007-01-11

  A URAT1 activity inhibitor containing a nitrogen-containing fused ring compound represented by the following formula [1]: wherein each symbol is as defined in the description. The present invention is useful for the prophylaxis or treatment of pathology showing involvement of uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urolithiasis, renal function disorder, coronary artery disease, ischemic heart disease and the like.

  一种包含氮含有融合环化合物的URAT1活性抑制剂，其化学式如下所示[1]： 其中每个符号如描述中所定义。本发明对于预防或治疗显示尿酸参与的病理学，如高尿酸血症、痛风石、急性痛风性关节炎、慢性痛风性关节炎、痛风性肾脏、尿路结石、肾功能障碍、冠状动脉疾病、缺血性心脏病等方面具有用处。
• [EN] THIAZOLE AND OXAZOLE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE À BASE DE THIAZOLE ET D'OXAZOLE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2009076140A1

  公开（公告）日：2009-06-18

  The present invention provides thiazole and oxazole compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.

  本发明提供了噻唑和恶唑化合物、含有该化合物的组合物，以及它们的制备方法和作为药物的应用方法。

表征谱图